Results 71 to 80 of about 1,410 (189)

Evolution of microparasites in spatially and genetically structured host populations: The example of RHDV infecting rabbits [PDF]

open access: yes, 2009
International ...
Fouchet, David   +5 more
core   +2 more sources

Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious

open access: yesVaccines, 2023
Vaccines play an important role in maintaining human and animal health worldwide. There is continued demand for effective and safe adjuvants capable of enhancing antigen-specific responses to a target pathogen.
Bassel Akache   +16 more
doaj   +1 more source

Facts about Wildlife Diseases: Rabbit Hemorrhagic Disease Virus Serotype 2 (RHDV2)

open access: yesEDIS, 2022
This publication provides information on rabbit hemorrhagic disease virus serotype 2 (RHDV2) and discusses infection, clinical signs, treatment, prevention, and reporting. Written by Catherine E. Dixon and Juan M.
Catherine E. Dixon   +1 more
doaj   +3 more sources

Immunogenicity of Multi-Target Chimeric RHDV Virus-Like Particles Delivering Foreign B-Cell Epitopes

open access: yesVaccines, 2022
The rabbit hemorrhagic disease virus (RHDV) vaccine platform is a nanoparticle composed of 180 copies of the viral capsid protein, VP60, self-assembled into virus-like particles (VLPs).
María Zamora-Ceballos   +5 more
doaj   +1 more source

Clinical chemistry, haematology, immune response and histological evaluation of rabbits after immunisation and challenge with rabbit haemorrhagic disease (RHD) virus [PDF]

open access: yes, 2017
Following their immunisation and infection with a VSHI-CN-6 viral strain, a group of 15 rabbits were examined in a study of Rabbit Haemorrhagic Disease (RHD).
Cristina, R. T.   +8 more
core   +4 more sources

Advancing ORFV‐Based Therapeutics to the Clinical Stage

open access: yesReviews in Medical Virology, Volume 35, Issue 3, May 2025.
ABSTRACT The Orf virus (ORFV) is the prototype member of the parapoxvirus family and has long been recognized for its robust immunogenicity, favourable safety profile and its ability to stimulate both cellular and humoural immune responses without inducing significant anti‐vector immunity.
Matthias Helmold, Ralf Amann
wiley   +1 more source

Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein [PDF]

open access: yes, 1995
Two myxoma virus-rabbit hemorrhagic disease virus (RHDV) recombinant viruses were constructed with the SG33 strain of myxoma virus to protect rabbits against myxomatosis and rabbit viral hemorrhagic disease.
Bertagnoli, Stéphane   +9 more
core   +2 more sources

Genotyping of rabbit hemorrhagic disease virus detected in diseased rabbits in Egyptian Provinces by VP60 sequencing [PDF]

open access: yesVeterinary World, 2020
Background and Aim: Rabbit hemorrhagic disease (RHD) is an economically important disorder of rabbits, where infection results in severe losses to the meat and fur industries.
Ahmed M. Erfan, Azhar G. Shalaby
doaj   +1 more source

Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review [PDF]

open access: yes, 2012
Rabbit haemorrhagic disease virus (RHDV) is a calicivirus of the genus Lagovirus that causes rabbit haemorrhagic disease (RHD) in adult European rabbits (Oryctolagus cuniculus).
Abrantes, Joana   +3 more
core   +5 more sources

Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39

open access: yesBritish Journal of Pharmacology, Volume 181, Issue 22, Page 4450-4490, November 2024.
Viroporins possess important potential as antiviral targets due to their critical roles during virus life cycles, spanning from virus entry to egress. Although the antiviral amantadine targets the M2 viroporin of influenza A virus, successful progression of other viroporin inhibitors into clinical use remains challenging.
Kira Devantier   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy